Recent reports have suggested that genetic polymorphisms in the alpha -2 ma
croglobulin (A2M) gene are associated with an increased risk for Alzheimer'
s disease. In the present study we tested two polymorphisms in the alpha -2
macroglobulin gene, a 5 bp deletion at the 5' splice site of exon 18 and a
G/A point mutation (V1000I) in exon 24, in a sample of 118 healthy, non de
mented controls and 238 consecutively recruited gerontopsychiatric patients
, diagnosed as: Alzheimer's disease (N = 88), mild cognitive impairment (N
= 32), subjective cognitive complaints (N = 54) and depression/other psychi
atric disorders (N = 64). The aim of this study was to test whether the inv
estigated polymorphisms has a high enough selectivity and specificity to di
stinguish between the different gerontopsychiatric disorders or to differen
tiate genetically AD from other forms of dementia, respectively. Also a pos
sible relation to the APOE epsilon4 polymorphism was examined. Our study fa
iled to show an association between the two investigated polymorphisms in t
he alpha -2 macroglobulin gene and any of the four different psychogeriatri
c patient subgroups, either alone or in combination with the APOE epsilon4
genotype. (C) 2000 Published by Elsevier Science Ireland Ltd.